Summit Place Financial Advisors LLC lifted its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 1.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,163 shares of the company’s stock after acquiring an additional 207 shares during the quarter. Summit Place Financial Advisors LLC’s holdings in Procter & Gamble were worth $2,256,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the stock. Nova Wealth Management Inc. acquired a new stake in shares of Procter & Gamble in the first quarter worth $26,000. Signature Resources Capital Management LLC boosted its position in shares of Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after buying an additional 72 shares during the period. Quarry LP acquired a new stake in shares of Procter & Gamble in the first quarter worth $33,000. Mizuho Securities Co. Ltd. boosted its position in shares of Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock worth $34,000 after buying an additional 170 shares during the period. Finally, RMG Wealth Management LLC acquired a new stake in shares of Procter & Gamble in the second quarter worth $37,000. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Price Performance
NYSE PG opened at $149.69 on Friday. Procter & Gamble Company has a fifty-two week low of $149.45 and a fifty-two week high of $180.43. The stock’s 50-day moving average is $155.24 and its two-hundred day moving average is $159.53. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The firm has a market cap of $350.34 billion, a P/E ratio of 22.99, a price-to-earnings-growth ratio of 3.99 and a beta of 0.36.
Analysts Set New Price Targets
PG has been the subject of several recent analyst reports. Barclays decreased their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. UBS Group reduced their price objective on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research report on Wednesday. BNP Paribas reissued an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Evercore ISI reissued an “in-line” rating and set a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Finally, Berenberg Bank lifted their price objective on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research report on Wednesday, September 17th. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $172.21.
Check Out Our Latest Stock Report on Procter & Gamble
Insider Activity at Procter & Gamble
In other news, CFO Andre Schulten sold 11,638 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,830,308.26. Following the transaction, the chief financial officer directly owned 52,642 shares in the company, valued at approximately $8,279,007.34. The trade was a 18.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Jon R. Moeller sold 40,119 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the transaction, the chief executive officer owned 319,375 shares in the company, valued at $50,228,106.25. The trade was a 11.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 149,763 shares of company stock valued at $23,421,279. Insiders own 0.20% of the company’s stock.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- What does consumer price index measure?
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- 3 Best Fintech Stocks for a Portfolio Boost
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.